Two doses of COVID-19 vaccination increased the SARM1 levels by 119.30%, 76.13%, and 143.13% in the HP group, T2DM group, and T2DMN group, respectively, compared with the median of the single-dose group. This evidence concerns the gene SARM1 and COVID-19.